CD34 + Stem Cell Augmentation of Allogeneic, Elutriated Marrow Grafts Improves Engraftment but Cyclosporine A Is Still Required to Reduce GVHD and Morbidity

Author: Noga S.J.   Vogelsang G.B.   Seber A.   Davis J.M.   Schepers K.   Hess A.D.   Jones R.J.  

Publisher: Elsevier

ISSN: 0041-1345

Source: Transplantation Proceedings, Vol.29, Iss.1, 1997-02, pp. : 728-732

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content